Heidi Tveit
Directeur Général chez Sana Pharma Medical AS
Profil
Heidi Tveit currently works at Sana Pharma Medical AS, as Chief Executive Officer from 2016 and Mallax Pharmaceuticals AB, as Chief Executive Officer.
Postes actifs de Heidi Tveit
| Sociétés | Poste | Début |
|---|---|---|
Sana Pharma Medical AS
 Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Directeur Général | 01/10/2016 |
Mallax Pharmaceuticals AB
 Mallax Pharmaceuticals AB Financial ConglomeratesFinance Mallax Pharmaceuticals AB is a Swedish pharmaceutical company that aims to build a portfolio of established pharmaceuticals and over-the-counter products for customers and patients. Mallax Pharmaceuticals has subsidiaries in Norway. The company was founded in 2020 by Anders Larnholt, and the CEO is Heidi Tveit. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sana Pharma Medical AS
Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Health Technology |
Mallax Pharmaceuticals AB
Mallax Pharmaceuticals AB Financial ConglomeratesFinance Mallax Pharmaceuticals AB is a Swedish pharmaceutical company that aims to build a portfolio of established pharmaceuticals and over-the-counter products for customers and patients. Mallax Pharmaceuticals has subsidiaries in Norway. The company was founded in 2020 by Anders Larnholt, and the CEO is Heidi Tveit. | Finance |
